{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T20:48:14Z","timestamp":1760042894221,"version":"3.37.3"},"reference-count":24,"publisher":"Public Library of Science (PLoS)","issue":"9","license":[{"start":{"date-parts":[[2016,9,9]],"date-time":"2016-09-09T00:00:00Z","timestamp":1473379200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003093","name":"Ministry of Higher Education, Malaysia","doi-asserted-by":"publisher","award":["H-20001-E00031"],"award-info":[{"award-number":["H-20001-E00031"]}],"id":[{"id":"10.13039\/501100003093","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0162760","type":"journal-article","created":{"date-parts":[[2016,9,9]],"date-time":"2016-09-09T19:17:24Z","timestamp":1473448644000},"page":"e0162760","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":19,"title":["Clinicopathological Features of Telbivudine-Associated Myopathy"],"prefix":"10.1371","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1022-1512","authenticated-orcid":true,"given":"Tomica","family":"Ambang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joo-San","family":"Tan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sheila","family":"Ong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kum-Thong","family":"Wong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5416-9627","authenticated-orcid":true,"given":"Khean-Jin","family":"Goh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2016,9,9]]},"reference":[{"issue":"2","key":"ref1","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1046\/j.1365-2893.2003.00487.x","article-title":"Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures","volume":"11","author":"D Lavanchy","year":"2004","journal-title":"Journal of viral hepatitis"},{"issue":"2","key":"ref2","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1002\/hep.21513","article-title":"Chronic hepatitis B","volume":"45","author":"AS Lok","year":"2007","journal-title":"Hepatology (Baltimore, Md)"},{"issue":"12","key":"ref3","doi-asserted-by":"crossref","first-page":"2715","DOI":"10.1093\/jac\/dkr388","article-title":"Nucleoside\/nucleotide analogues in the treatment of chronic hepatitis B","volume":"66","author":"J Fung","year":"2011","journal-title":"The Journal of antimicrobial chemotherapy"},{"issue":"3","key":"ref4","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1111\/jgh.12499","article-title":"Extrahepatic effects of nucleoside and nucleotide analogues in chronic hepatitis B treatment","volume":"29","author":"J Fung","year":"2014","journal-title":"Journal of gastroenterology and hepatology"},{"issue":"4","key":"ref5","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/j.jhep.2009.06.011","article-title":"Myopathy and neuropathy associated with nucleos(t)ide analog therapy for hepatitis B","volume":"51","author":"RD Fleischer","year":"2009","journal-title":"Journal of hepatology"},{"issue":"33","key":"ref6","doi-asserted-by":"crossref","first-page":"5575","DOI":"10.3748\/wjg.v19.i33.5575","article-title":"Lactic acidosis during telbivudine treatment for HBV: a case report and literature review","volume":"19","author":"JL Jin","year":"2013","journal-title":"World journal of gastroenterology: WJG"},{"issue":"11","key":"ref7","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1136\/jclinpath-2013-202069","article-title":"Lamivudine\/telbivudine-associated neuromyopathy: neurogenic damage, mitochondrial dysfunction and mitochondrial DNA depletion","volume":"67","author":"H Xu","year":"2014","journal-title":"Journal of clinical pathology"},{"issue":"3","key":"ref8","first-page":"863","article-title":"Rhabdomyolysis due to Lamivudine administration in acute viral hepatitis B infection: a case report from Malaysia","volume":"6","author":"J Baharin","year":"2014","journal-title":"Electronic physician"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1186\/1743-422X-7-323","article-title":"Myotoxicity of telbivudine in pre-existing muscle damage","volume":"7","author":"J Finsterer","year":"2010","journal-title":"Virology Journal"},{"issue":"1","key":"ref10","doi-asserted-by":"crossref","first-page":"82","DOI":"10.3350\/cmh.2013.19.1.82","article-title":"Two cases of telbivudine-induced myopathy in siblings with chronic hepatitis B","volume":"19","author":"EH Kim","year":"2013","journal-title":"Clinical and molecular hepatology"},{"issue":"9","key":"ref11","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1111\/imj.12237","article-title":"Dysphagia could be the first presenting symptom of telbivudine-induced myopathy","volume":"43","author":"SW Lee","year":"2013","journal-title":"Internal medicine journal"},{"issue":"1","key":"ref12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12072-015-9675-4","article-title":"Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update","volume":"10","author":"SK Sarin","year":"2016","journal-title":"Hepatology international"},{"issue":"2","key":"ref13","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1053\/j.gastro.2008.10.026","article-title":"2-Year GLOBE trial results: telbivudine Is superior to lamivudine in patients with chronic hepatitis B","volume":"136","author":"YF Liaw","year":"2009","journal-title":"Gastroenterology"},{"issue":"12","key":"ref14","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1111\/j.1365-2893.2010.01412.x","article-title":"Clinical features and risk factors of creatine kinase elevations and myopathy associated with telbivudine","volume":"18","author":"XJ Zou","year":"2011","journal-title":"Journal of viral hepatitis"},{"issue":"3","key":"ref15","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1007\/s11096-012-9633-3","article-title":"Telbivudine myopathy in a patient with chronic hepatitis B","volume":"34","author":"M Wang","year":"2012","journal-title":"International journal of clinical pharmacy"},{"key":"ref16","first-page":"681","article-title":"Myology: Basic and Clinical","author":"AG Engel","year":"2004"},{"issue":"6","key":"ref17","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1016\/j.ajpath.2012.08.033","article-title":"Immune-mediated necrotizing myopathy is characterized by a specific Th1-M1 polarized immune profile","volume":"181","author":"C Preu\u00dfe","year":"2012","journal-title":"The American journal of pathology"},{"unstructured":"Department of Health U.S. and Human Services, National Institute of Health, National Cancer Institute. Common Terminology Criteria for Adverse Events v4.0 2009. Available: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/evs.nci.nih.gov\/ftp1\/CTCAE\/CTCAE_4.03_2010-06-14_QuickReference_5x7.pdf\" xlink:type=\"simple\">http:\/\/evs.nci.nih.gov\/ftp1\/CTCAE\/CTCAE_4.03_2010-06-14_QuickReference_5x7.pdf<\/ext-link>.","key":"ref18"},{"issue":"1","key":"ref19","first-page":"117","article-title":"Creatine kinase elevations during 4 years telbivudine anti-hepatitis B virus treatment are not predictive of muscle events (abstract)","volume":"5","author":"M Jung","year":"2011","journal-title":"Hepatol Int"},{"key":"ref20","first-page":"120","article-title":"Analyses of multiple telbivudine studies show creatine kinase elevations do not predict muscle events during chronichepatitis B treatment (abstract)","volume":"6","author":"Y Dong","year":"2012","journal-title":"Hepatol Int"},{"issue":"6","key":"ref21","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.1002\/hep.22959","article-title":"Long-term therapy with clevudine for chronic hepatitis B can be associated with myopathy characterized by depletion of mitochondrial DNA","volume":"49","author":"JI Seok","year":"2009","journal-title":"Hepatology (Baltimore, Md)"},{"issue":"16","key":"ref22","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1056\/NEJM199004193221602","article-title":"Mitochondrial myopathy caused by long-term zidovudine therapy","volume":"322","author":"MC Dalakas","year":"1990","journal-title":"The New England journal of medicine"},{"issue":"1","key":"ref23","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1128\/AAC.45.1.229-235.2001","article-title":"Antiviral L-nucleosides specific for hepatitis B virus infection","volume":"45","author":"ML Bryant","year":"2001","journal-title":"Antimicrobial agents and chemotherapy"},{"issue":"1\u20132","key":"ref24","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/0022-510X(90)90006-9","article-title":"Cytochrome c oxidase deficient fibres in the limb muscle and diaphragm of man without muscular disease: an age-related alteration","volume":"100","author":"J Muller-Hocker","year":"1990","journal-title":"Journal of the neurological sciences"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0162760","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T04:54:14Z","timestamp":1589000054000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0162760"}},"subtitle":[],"editor":[{"given":"Jose Ignacio","family":"Herrero","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2016,9,9]]},"references-count":24,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2016,9,9]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0162760","relation":{},"ISSN":["1932-6203"],"issn-type":[{"type":"electronic","value":"1932-6203"}],"subject":[],"published":{"date-parts":[[2016,9,9]]}}}